A detailed history of Tekla Capital Management LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Tekla Capital Management LLC holds 459,651 shares of TEVA stock, worth $7.87 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
459,651
Previous 459,651 -0.0%
Holding current value
$7.87 Million
Previous $4.07 Million 14.9%
% of portfolio
0.14%
Previous 0.16%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$7.9 - $10.19 $1.17 Million - $1.51 Million
-148,000 Reduced 24.36%
459,651 $3.68 Million
Q2 2021

Aug 13, 2021

SELL
$9.9 - $11.56 $523,710 - $611,524
-52,900 Reduced 8.01%
607,651 $6.02 Million
Q1 2021

May 14, 2021

SELL
$10.34 - $12.81 $718,630 - $890,295
-69,500 Reduced 9.52%
660,551 $7.62 Million
Q4 2020

Feb 12, 2021

SELL
$8.61 - $11.04 $480,437 - $616,032
-55,800 Reduced 7.1%
730,051 $7.05 Million
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $853,720 - $1.65 Million
-105,138 Reduced 11.8%
785,851 $7.25 Million
Q1 2019

May 14, 2019

SELL
$15.58 - $20.01 $5 Million - $6.42 Million
-320,879 Reduced 26.48%
890,989 $14 Million
Q4 2018

Feb 13, 2019

BUY
$14.59 - $23.84 $4.07 Million - $6.65 Million
278,920 Added 29.9%
1,211,868 $18.7 Million
Q3 2018

Nov 13, 2018

SELL
$21.06 - $25.65 $3.18 Million - $3.87 Million
-150,895 Reduced 13.92%
932,948 $20.1 Million
Q2 2018

Aug 13, 2018

BUY
$16.77 - $24.71 $10,397 - $15,320
620 Added 0.06%
1,083,843 $26.4 Million
Q1 2018

May 14, 2018

SELL
$16.68 - $22.07 $8.34 Million - $11 Million
-499,885 Reduced 31.58%
1,083,223 $18.5 Million
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $1.95 Million - $3.31 Million
-173,450 Reduced 9.87%
1,583,108 $30 Million
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $11.4 Million - $23.8 Million
740,800 Added 72.93%
1,756,558 $30.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,015,758
1,015,758 $33.7 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.